Intratumoral and intertumoral heterogeneity of HER2 immunohistochemical expression in gastric cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Intratumoral and intertumoral heterogeneity of HER2 immunohistochemical expression in gastric cancer

Published:2020-11 Issue:11 Volume:216 Page:153229
ISSN:0344-0338
Container-title:Pathology - Research and Practice
language:en
Short-container-title:Pathology - Research and Practice

Author:

Zhang He,Wang Yi,Wang Yanfeng,Wu Daoyuan,Lin Enguang,Xia Qingxin

Funder

Science and Technology Project of Henan province

Doctoral Research Initiation Fund of Affiliated Cancer Hospital of Zhengzhou University

Publisher

Elsevier BV

Subject

Cell Biology,Pathology and Forensic Medicine

Reference37 articles.

1. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;Bray;CA Cancer J. Clin.,2018

2. Characterization and validation of somatic mutation spectrum to reveal heterogeneity in gastric cancer by single cell sequencing;Peng;Sci. Bull.,2019

3. Targeted therapy for gastric cancer: current status and future directions;Yuan;Oncol. Rep.,2016

4. HER2 in gastric cancer: a new prognostic factor and a novel therapeutic target;Gravalos;Ann. Oncol.,2008

5. Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial;Bang;Lancet,2010

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Thirdhand smoke exposure promotes gastric tumor development in mouse and human;Environment International;2024-09

2. Human Epidermal Growth Factor 2 (Her-2) Expression in Gastric and Gastroesophageal Carcinomas: A Clinicopathological Evaluation in a Tertiary Care Institute;Cureus;2024-08-27

3. Resistance to Anti-HER2 Therapies in Gastrointestinal Malignancies;Cancers;2024-08-15

4. HER2 and PD-L1 Expression in Gastric and Gastroesophageal Junction Cancer: Insights for Combinatorial Targeting Approaches;Cancers;2024-03-20

5. HER2 Prognostic Significance and Therapeutic Implications in Gastric Cardia Adenocarcinoma: Insights from Multi-Omics Profiling;2024-03-06

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3